Moderate to severe ulcerative colitis
Showing 1 - 25 of >10,000
Ulcerative Colitis Trial in Kissimmee (Rosnilimab, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Rosnilimab
- Placebo
-
Kissimmee, FloridaAnaptysBio Investigative Site 10-101
Nov 7, 2023
Assess Safety of Ozanimod in Moderate to Severe Active UC in
Not yet recruiting
- Ulcerative Colitis
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Ulcerative Colitis Trial (NX-13 250mg, NX-13 750mg, NX-13 Placebo)
Not yet recruiting
- Ulcerative Colitis
- NX-13 250mg
- +2 more
- (no location specified)
Mar 28, 2023
Ulcerative Colitis (UC) Trial in Guangzhou (Placebo, IBI112)
Recruiting
- Ulcerative Colitis (UC)
- Placebo
- IBI112
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Sun Yat-sen University
Sep 20, 2022
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
Recruiting
- Moderate to Severe Ulcerative Colitis
-
Guandong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Milano (bowel ultrasound, colonoscopy)
Recruiting
- Ulcerative Colitis Chronic Moderate
- Ulcerative Colitis Chronic Severe
- bowel ultrasound
- colonoscopy
-
Milano, ItalyMariangela Allocca
Feb 9, 2023
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Spain (OST-122, Placebo)
Completed
- Ulcerative Colitis Chronic Moderate
- Ulcerative Colitis Chronic Severe
- OST-122
- Placebo
-
Santiago de Compostela, A Coruña, Spain
- +15 more
Jan 11, 2023
Crohn Disease, Colitis, Ulcerative Trial (TEV-48574 Dose Regimen A, TEV-48574 Dose Regiment B)
Recruiting
- Crohn Disease
- Colitis, Ulcerative
- TEV-48574 Dose Regimen A
- TEV-48574 Dose Regiment B
-
Kissimmee, FloridaTeva Investigational Site 15357
Feb 2, 2023
Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)
Not yet recruiting
- Exclusive Enteral Nutrition
- +2 more
- exclusive enteral nutrition
- regular food
- (no location specified)
Dec 5, 2022
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe, Rectal Ulcer Trial in Xi'an (other, drug, biological)
Not yet recruiting
- Ulcerative Colitis Chronic Moderate
- +2 more
- Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment
- +3 more
-
Xi'an, Shaanxi, ChinaXijing Digestive Disease
Jun 12, 2023
Disease Activity and Adverse Events of Rinvoq in Adult Moderate
Recruiting
- Ulcerative Colitis
-
Kurume-shi, Fukuoka, Japan
- +4 more
Mar 17, 2023
Moderate to Severe Ulcerative Colitis Patients Treated With
Recruiting
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- Procedure: endoscopic biopsy
- +2 more
-
Nancy, Lorraine, FranceCentral Hospital
Jul 11, 2022
Crohn Disease, Colitis, Ulcerative Trial (TEV-48574, Placebo)
Not yet recruiting
- Crohn Disease
- Colitis, Ulcerative
- TEV-48574
- Placebo
- (no location specified)
Aug 11, 2022
Ulcerative Colitis Trial in San Antonio (TLL018, Placebo)
Withdrawn
- Ulcerative Colitis
- TLL018
- Placebo
-
San Antonio, TexasGastroenterology Research of San Antonio (GERSA)
May 9, 2022
Vedolizumab SC Given to Moderate to Severe Ulcerative Colitis or
Not yet recruiting
- Ulcerative Colitis
- +2 more
- (no location specified)
Jun 24, 2022
Adult Moderate-to-Severe Ulcerative Colitis
Active, not recruiting
- Ulcerative Colitis
-
Murrieta, California
- +62 more
Jan 17, 2023
Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative
Completed
- Colitis, Ulcerative
- No Intervention
-
Ansan-si, Korea, Republic of
- +14 more
Mar 30, 2022
Ulcerative Colitis Trial in United States (Hyperbaric Oxygen Therapy, Sham Hyperbaric Air)
Not yet recruiting
- Ulcerative Colitis
- Hyperbaric Oxygen Therapy
- Sham Hyperbaric Air
-
Birmingham, Alabama
- +18 more
Aug 9, 2023
Ulcerative Colitis, Infliximab, Children Trial in Shanghai (Infliximab, Corticosteroids)
Recruiting
- Ulcerative Colitis
- +2 more
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Feb 5, 2022
